vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $30.3M, roughly 1.5× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -19.9%, a 7.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -9.5%). SYPRIS SOLUTIONS INC produced more free cash flow last quarter ($-1.5M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -7.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
ABCL vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $30.3M |
| Net Profit | $-8.9M | $-3.9M |
| Gross Margin | — | 4.6% |
| Operating Margin | -63.7% | -10.9% |
| Net Margin | -19.9% | -12.9% |
| Revenue YoY | 788.4% | -9.5% |
| Net Profit YoY | 73.9% | -2992.6% |
| EPS (diluted) | $-0.03 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $30.3M | ||
| Q3 25 | $9.0M | $28.7M | ||
| Q2 25 | $17.1M | $31.4M | ||
| Q1 25 | $4.2M | $29.5M | ||
| Q4 24 | $5.0M | $33.4M | ||
| Q3 24 | $6.5M | $35.7M | ||
| Q2 24 | $7.3M | $35.5M | ||
| Q1 24 | $10.0M | $35.6M |
| Q4 25 | $-8.9M | $-3.9M | ||
| Q3 25 | $-57.1M | $517.0K | ||
| Q2 25 | $-34.7M | $-2.1M | ||
| Q1 25 | $-45.6M | $-899.0K | ||
| Q4 24 | — | $135.0K | ||
| Q3 24 | $-51.1M | $390.0K | ||
| Q2 24 | $-36.9M | $16.0K | ||
| Q1 24 | $-40.6M | $-2.2M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 11.4% | ||
| Q4 24 | — | 16.1% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | — | 8.1% |
| Q4 25 | -63.7% | -10.9% | ||
| Q3 25 | -851.8% | -6.1% | ||
| Q2 25 | -290.2% | -4.6% | ||
| Q1 25 | -1479.6% | -0.4% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | -1439.4% | 4.8% | ||
| Q2 24 | -1276.2% | 3.6% | ||
| Q1 24 | -551.5% | -3.9% |
| Q4 25 | -19.9% | -12.9% | ||
| Q3 25 | -637.8% | 1.8% | ||
| Q2 25 | -203.3% | -6.5% | ||
| Q1 25 | -1077.2% | -3.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | -785.4% | 1.1% | ||
| Q2 24 | -504.3% | 0.0% | ||
| Q1 24 | -408.0% | -6.2% |
| Q4 25 | $-0.03 | $-0.17 | ||
| Q3 25 | $-0.19 | $0.02 | ||
| Q2 25 | $-0.12 | $-0.09 | ||
| Q1 25 | $-0.15 | $-0.04 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | $-0.17 | $0.02 | ||
| Q2 24 | $-0.13 | $0.00 | ||
| Q1 24 | $-0.14 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $17.8M |
| Total Assets | $1.4B | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | $17.8M | ||
| Q3 25 | $964.0M | $20.0M | ||
| Q2 25 | $1.0B | $18.7M | ||
| Q1 25 | $1.0B | $19.0M | ||
| Q4 24 | $1.1B | $19.6M | ||
| Q3 24 | $1.1B | $18.2M | ||
| Q2 24 | $1.1B | $19.0M | ||
| Q1 24 | $1.1B | $20.8M |
| Q4 25 | $1.4B | $107.8M | ||
| Q3 25 | $1.4B | $112.5M | ||
| Q2 25 | $1.4B | $105.8M | ||
| Q1 25 | $1.3B | $110.2M | ||
| Q4 24 | $1.4B | $119.4M | ||
| Q3 24 | $1.4B | $121.6M | ||
| Q2 24 | $1.4B | $124.2M | ||
| Q1 24 | $1.5B | $129.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-1.1M |
| Free Cash FlowOCF − Capex | $-44.6M | $-1.5M |
| FCF MarginFCF / Revenue | -99.4% | -5.0% |
| Capex IntensityCapex / Revenue | 21.9% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-1.1M | ||
| Q3 25 | $-52.6M | $-178.0K | ||
| Q2 25 | $-32.4M | $1.1M | ||
| Q1 25 | $-11.6M | $-5.5M | ||
| Q4 24 | $-108.6M | $2.3M | ||
| Q3 24 | $-28.9M | $-4.8M | ||
| Q2 24 | $-30.0M | $6.2M | ||
| Q1 24 | $-41.7M | $-1.7M |
| Q4 25 | $-44.6M | $-1.5M | ||
| Q3 25 | $-61.5M | $-390.0K | ||
| Q2 25 | $-45.8M | $941.0K | ||
| Q1 25 | $-22.2M | $-5.5M | ||
| Q4 24 | $-187.0M | $1.9M | ||
| Q3 24 | $-47.4M | $-4.9M | ||
| Q2 24 | $-50.1M | $6.0M | ||
| Q1 24 | $-65.8M | $-2.0M |
| Q4 25 | -99.4% | -5.0% | ||
| Q3 25 | -687.0% | -1.4% | ||
| Q2 25 | -267.9% | 3.0% | ||
| Q1 25 | -524.0% | -18.8% | ||
| Q4 24 | -3702.8% | 5.7% | ||
| Q3 24 | -728.4% | -13.8% | ||
| Q2 24 | -683.8% | 16.8% | ||
| Q1 24 | -661.5% | -5.7% |
| Q4 25 | 21.9% | 1.3% | ||
| Q3 25 | 99.7% | 0.7% | ||
| Q2 25 | 78.2% | 0.5% | ||
| Q1 25 | 251.1% | 0.0% | ||
| Q4 24 | 1552.7% | 1.2% | ||
| Q3 24 | 284.6% | 0.4% | ||
| Q2 24 | 274.6% | 0.5% | ||
| Q1 24 | 242.5% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
